Search for Clinical Trial Results

Sponsored By

Familial Hypophosphatemic Rickets - 21 Studies Found

Status Study
Recruiting Study Name: Calcimimetics in Hypophosphatemic Rickets
Condition: Familial Hypophosphatemic Rickets
Date: 2009-02-12
Interventions: Drug: Cinacalcet Stable patients with XLH already treated with Phosphate and calcitriol will add Cinacal
Completed Study Name: A Study of KRN23 in X-linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Date: 2009-01-27
Interventions:
  • Drug: Placebo single dose IV o
Completed Study Name: A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Date: 2011-04-15
Interventions: Drug: KRN23 Subjects will receive escalating doses of KRN23 administered by SC injections every 28-days
Completed Study Name: An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Condition: X-linked Hypophosphatemia
Date: 2012-02-23
Interventions: Drug: KRN23 Subjects will receive escalating doses of KRN23 administered by SC injection every 28-days (
Enrolling by invitation Study Name: Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2014-12-03
Interventions: Drug: KRN23 KRN23 is a recombinant fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that b
Active, not recruiting Study Name: Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Date: 2015-07-17
Interventions:
  • Biological: KRN23 KRN23 is a r
Active, not recruiting Study Name: Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Date: 2014-06-09
Interventions: Drug: KRN23
Active, not recruiting Study Name: Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)
Condition: X-linked Hypophosphatemia
Date: 2015-08-25
Interventions: Biological: KRN23 KRN23 is a recombinant human immunoglobulin G isotype 1 (IgG1) monoclonal antibody (mA
Active, not recruiting Study Name: Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2015-12-06
Interventions: Drug: KRN23
Recruiting Study Name: Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)
Condition: X-Linked Hypophosphatemia
Date: 2016-05-23
Interventions:
  • Biological: KRN23 KRN23 is a r
Next >>>